Product Information
IBANDRONATE 3 MG/3 ML SYRINGE is a generic product labeled by Mylan Institutional LLC, priced at $54.2117 per ML under NDC 67457052433. Its NADAC has been published 80 times since Nov 20, 2024.
Strength
3 mg/3mL
Manufacturer
Mylan Institutional LLCNDC
67457052433
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Last Updated
3/18/2026
Active Ingredients
IBANDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202671On Market Since
9/2/2014
Pharmacological Classes
Price Statistics
The NADAC for IBANDRONATE 3 MG/3 ML SYRINGE has been published 80 times since Nov 20, 2024, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $54.2117 per ML |
|---|---|
| All-time high | $54.2117 (May 27, 2026) |
| All-time low | $49.5953 (Oct 22, 2025) |
| 52-week high | $54.2117 |
| 52-week low | $49.5953 |
| Median price | $53.3244 |
| Average price | $52.9088 |
| Largest weekly change | -7.0% (Oct 22, 2025) |
| Weeks tracked | 80 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBANDRONATE 3 MG/3 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE 3 MG/3 ML SYRINGE, manufactured by Mylan Institutional LLC, is $54.2117 per ML (NDC 67457052433), effective May 27, 2026.
How has the price of IBANDRONATE 3 MG/3 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for IBANDRONATE 3 MG/3 ML SYRINGE has risen 3.4%. It has been tracked across 80 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for IBANDRONATE 3 MG/3 ML SYRINGE?
Since Nov 20, 2024, the NADAC for IBANDRONATE 3 MG/3 ML SYRINGE has ranged from a low of $49.5953 (Oct 22, 2025) to a high of $54.2117 (May 27, 2026), with a median of $53.3244 per ML.
Are there cheaper alternatives to IBANDRONATE 3 MG/3 ML SYRINGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IBANDRONATE 3 MG/3 ML SYRINGE, but none are currently priced below it.
Who manufactures IBANDRONATE 3 MG/3 ML SYRINGE?
IBANDRONATE 3 MG/3 ML SYRINGE (NDC 67457052433) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification